Swiss chemical company Clariant reached an agreement with the WEF (World Economic Forum) and major chemical companies to establish a breakthrough development platform by 2023. A Project Development Company will be designed as a new stand-alone entity operating on a pre-competitive basis and supporting partners in setting set-up joint projects aiming to share early-stage development risks and invest jointly in the development and implementationof low-carbon technologies.
Clariant, a focused, sustainable and innovative specialty chemical company, last Friday announced the official completion of its sunliquid® cellulosic ethanol plant in Podari, Romania. The completed construction is an important next step for the commercial deployment of sunliquid® technology and thus supports Clariant’s sunliquid® licensing business strategy. The facility will be operational in the fourth quarter, producing cellulosic ethanol from agricultural residues.
Clariant, a focused, sustainable and innovative specialty chemical company, and India Glycols Limited (IGL), a leading company in the manufacturing of green technology-based chemicals, successfully created their 51-49% joint venture for renewable ethylene oxide (EO) derivatives after receiving all necessary regulatory approvals. The joint venture will operate under the name Clariant IGL Specialty Chemicals Private Limited.
Clariant, a focused, sustainable, and innovative specialty chemical company, is working with Indonesia’s state-owned oil and gas corporation, Pertamina, since 2018 to evaluate and test the feasibility of Clariant’s sunliquid®technology to process available regional feedstocks in Indonesia into the advanced biofuel, cellulosic ethanol.
Clariant, a focused, sustainable and innovative specialty chemical company, signed a license agreement with Harbin Hulan Sino-Dan Jianye Bio-Energy, a Chinese green energy company for its sunliquid® cellulosic ethanol technology.
Bilfinger has been commissioned by the Swiss specialty chemical company Clariant to deliver EPCM (engineering, procurement, overall project and construction management) services for the construction of their commercial-scale cellulosic ethanol production plant using Clariant’s sunliquid® technology in southwest Romania.
Clariant’s Business Line Biofuels and Derivatives announced on August 15 during a joint presentation at the 7thAsia-Pacific Biomass Utilization Summit in Guangzhou that a strategic partnership has been formed with Chemtex Global Corporation for the realization of second-generation biofuel projects. Under the partnership, the two parties will collaborate to market and sell Clariant’s sunliquid®technology licenses, as well as services and supplies for advanced biofuel plants in China.
Swiss chemical giant Clariant joined forces with Ineratec in the challenge for a greener future. The companies entered a partnership to develop and commercialize novel technologies for the production of renewable fuels and chemicals. Clariant will provide its extensive catalysis expertise and broad portfolio of syngas conditioning and upgrading catalysts to support Ineratec’s groundbreaking gas-to-liquid technology.
Clariant and Duslo’s research institute VUCHT are transforming waste into wealth. Using a proprietary technique and Clariant’s HYDEX E next-generation hydro-dewaxing catalyst, VUCHT has successfully converted plastic waste into premium winter fuel distillate. The efficacy of this groundbreaking process has now been proven in a pilot plant in Slovakia. As plastics and fuels are both mainly composed of natural gas or crude oil, turning one into the other has major implications for sustainable and lucrative fuel production.
Clariant, a focused and innovative specialty chemical company, today announced it has started monthly production of 2 million liters of disinfectant at its facilities in Gendorf, Germany. This disinfectant is then directly or via repacking partners provided to regional hospitals and other vital institutions in Bavaria, who are currently facing limited availability of this critical product during the COVID-19 outbreak.
IL BIOECONOMISTA 